Navigation Links
Bio-Matrix Scientific Group Announces New Hires to Management Team
Date:2/25/2009

SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) announced today that it has added two members to newly created positions on its management team. Feng Lin, M.D., Ph.D. has joined the biotech research and development company as Laboratory/Scientific Director and Marilyn Panahi is serving as Quality Assurance Director.

"Dr. Feng Lin and Marilyn Panahi bring tremendous expertise to the administrative operations of BMSN's laboratories to ensure all of the varied facets meet government regulations and compliance," said David Koos, Chairman and CEO, BMSN.

As Laboratory/Scientific Director, Dr. Lin is responsible for the overall operation, leadership, direction, and administration of BMSN's Laboratory in accordance with Federal and State Regulations governing laboratories.

As Quality Assurance Director, Ms. Panahi is responsible for managing and assuring regulatory compliance requirements including validation, customer complaints, and review of product manufacture records, audits, and quality assurance documentation. .

Dr. Feng Lin has a strong background in drug/DNA in vivo delivery, oncology and tumor immunotherapy, DNA vaccination, cell and molecular biology, and animal model work. He also has extensive experience with tissue imaging, DNA vaccine design, antibody- and cell-based assay. Previously, Dr. Lin was a Senior Research Scientist, Research & Development with Inovio Biomedical Corp., San Diego. He received his M.D. from Central South University Xiag-Ya School of Medicine, Changsha, China, along with a M.S. Biochemistry & Molecular Biology and a Ph.D. Hematology & Physiology from the same institution. Dr. Lin's research work has been widely published in international scientific journals.

Marilyn Panahi brings more than 15 years experience in the implementation and management of the EPA's Good Laboratory Practice Standards (GLPS) Compliance Monitoring Program and the FDA's Good Manufacturing Practices (GMP)/Quality Systems Regulation.

Previously, Ms. Panahi was Quality Manager, Therapheresis, Inc., San Diego. Ms. Panahi is a graduate of San Diego State University with a B.S. in Microbiology. Ms. Panahi also holds a Certificate in Science of Regulatory Affairs for the Drug and Biologic Industry and a Certificate in Quality Assurance/Control for the Drug and Biologic Industry, both from the University of California at San Diego.

About Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN)

Bio-Matrix Scientific Group, Inc., based in San Diego, is a biotech research and development company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix's new 15,000 sq. ft. facility, located in the heart of San Diego's biotechnology corridor, houses the company's two secure Cryogenic Stem Cell Banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.


'/>"/>
SOURCE Bio-Matrix Scientific Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Bert W. OMalley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovos Scientific Advisory Board
2. Former SADMERC Medical Directors Join OrthoCare Innovations as Medical and Scientific Advisory Board Members and Strategic Advisors
3. Weed Science Society of America Announces Winners in Annual Scientific Awards Program
4. Arts Way Manufacturing Announces Launch of New Web Site For Arts Way Scientific - Buildings For Science
5. AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
6. Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries
7. BioSpace Partners with Journal of Visualized Experiments (JoVE) to Offer Peer-Reviewed Scientific Video Content on BioSpace.com
8. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
9. A Scientific Milestone: Sex of Dolphin at SeaWorld San Diego Determined Prior to Conception
10. Boston Scientific Acquires Labcoat Limited
11. Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... N.J. , May 4, 2016  Bayer ... its oncology compound Stivarga ® (regorafenib) tablets ... carcinoma (HCC) has met its primary endpoint of ... study, called RESORCE, evaluated the efficacy and safety ... has progressed after treatment with sorafenib. The safety ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nutrafol®, a first-to-market ... treat hormonal and stress related hair loss. With patent-pending formulas for both female ... opinion leaders in the medical and salon channels nationwide. , Dermatologists, Plastic ...
(Date:5/3/2016)... ... May 03, 2016 , ... Leading CEOs from ... May 31st and June 1st at The Four Seasons Hotel Boston. , The ... life sciences, offering exclusive access to key decision makers who influence deal making ...
(Date:5/3/2016)... 3, 2016 - And Other ... Producers of Those Competitor Biologics  - Biosimilar ... and Prospects ,  Who are the most ... what are their sales potentials? Discover, in our updated ... trends, opportunities and revenue forecasting. Visiongain,s ...
Breaking Biology Technology:
(Date:3/11/2016)... India , March 11, 2016 ... a new market research report "Image Recognition Market by ... Application (Marketing and Advertising), by Deployment Type (On-Premises and ... Forecast To 2022", published by MarketsandMarkets, the global market ... 2015 to USD 29.98 Billion by 2020, at a ...
(Date:3/9/2016)... , March 9, 2016 This BCC Research ... states of the RNA Sequencing (RNA Seq) market for ... as instruments, tools and reagents, data analysis, and services. ... segments of the RNA-Sequencing market such as RNA-Sequencing tools ... the main factors affecting each segment and forecast their ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
Breaking Biology News(10 mins):